Enoxaparin in unstable angina patients with renal failure

被引：71

作者：

Collet, JP

Montalescot, G

Choussat, R

Lison, L

Ankri, A

机构：

[1] CHU Pitie Salpetriere, Dept Cardiol, F-75013 Paris, France

[2] Hop La Pitie Salpetriere, Hemostase Lab, F-75013 Paris, France

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2001年 / 80卷 / 01期

关键词：

low molecular weight heparin; unstable angina; renal failure;

D O I：

10.1016/S0167-5273(01)00455-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The dosage of the subcutaneous low molecular weight heparin enoxaparin in unstable angina patients undergoing coronary angiogram and coronary angioplasty depends clearly on the renal function. It should be significantly reduced to 64% of the standard dose (1 mg/kg per 12 h) in patients with severe renal failure (creatinine clearance < 30 ml/min) to provide a safe anticoagulant profile. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.

引用

页码：81 / 82

页数：2

共 6 条

[1] Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction - TIMI 11B-ESSENCE meta-analysis
Antman, EM
Cohen, M
Radley, D
McCabe, C
Rush, J
Premmereur, J
Braunwald, E
[J]. CIRCULATION, 1999, 100 (15) : 1602 - 1608
[2] Braunwald E, 1997, J AM COLL CARDIOL, V29, P1474
[3] Collet JP, 2001, CIRCULATION, V103, P658
[4] Kereiakes DJ, 2000, J INVASIVE CARDIOL, V12, p1A
[5] Mismetti P, 1998, THROMB HAEMOSTASIS, V79, P1162
[6] Low molecular weight heparin after mechanical heart valve replacement
Montalescot, G
Polle, V
Collet, JP
Leprince, P
Bellanger, A
Gandjbakhch, I
Thomas, D
[J]. CIRCULATION, 2000, 101 (10) : 1083 - 1086

← 1 →